Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.
Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in Chicago. The trial is currently enrolling advanced melanoma or triple ... Read more
Ignyta’s candidate product entrectinib has shown promise as a treatment for several cancer types including melanoma, according to results of two Phase 1 clinical trials. Treatment with entrectinib was well-tolerated ... Read more
Researchers at the Penn State College of Medicine developed a novel drug to fight melanoma called CelePlum-777, a set of nanoparticles loaded with the anticancer drugs celecoxib and plumbagin, and that ... Read more
Researchers have found that a protein, called p15, may be used as a biomarker to distinguish melanoma from nevi (non-cancerous moles in the skin). Loss of this protein, which inhibits nevus ... Read more
Therapies that target elements of the immune system or certain pathways active in cancer cells, in combination with radiation therapy, may work better than chemotherapy for patients with melanoma brain metastases, according ... Read more
A new study suggests that mass spectrometry imaging, a technique that allows the identification of several molecules, such as metabolites, peptides and proteins, DNA segments, and lipids from tissue samples, ... Read more